Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | microtubule associated protein 2 | 0.0782 | 0.3818 | 0.3634 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.1955 | 1 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0057 | 0 | 0.5 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0071 | 0.0071 | 0.0063 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.1955 | 1 | 1 |
Schistosoma mansoni | sodium-bile acid cotransporter | 0.1162 | 0.5823 | 0.5752 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0186 | 0.0681 | 0.5 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.1955 | 1 | 1 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0354 | 0.1563 | 1 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0354 | 0.1563 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1955 | 1 | 1 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.1955 | 1 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0782 | 0.3818 | 0.3634 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.1955 | 1 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0354 | 0.1563 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0354 | 0.1563 | 1 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.1955 | 1 | 1 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.0793 | 0.3876 | 0.3772 |
Mycobacterium ulcerans | hypothetical protein | 0.0186 | 0.0681 | 0.5 |
Onchocerca volvulus | 0.1955 | 1 | 0.5 | |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0167 | 0.0582 | 0.3643 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0782 | 0.3818 | 0.3713 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.1955 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.